For life science investors
Investor interest in the Australian life sciences is strong, stemming from the nation’s top ranking in the global life sciences and its diverse suite of investor opportunities in biotechnology and pharmaceuticals.
AusBiotech is committed to fostering relationships between life science companies and investors, assisting investors to connect with innovative, Australian companies that offer high-value return-on-investment.
Fast facts
- Australia's ASX-listed life sciences sector valued at $100.042 billion1
- Australian biotechnology industry attracted record deals flows $1.384 billion of capital raising2
- 64% of respondents to the AusBiotech CEO Survey, 2017 expected to hire more staff throughout the year3
- Ranked among the global top five for biotechnology innovation for the third consecutive year4
About the Australian life science industry
Life science innovation in Australia has a proven track-record, with a vaccine to present cervical cancer and a medical device enabling deaf patients to hear among the most-often-cited examples.
Australia is a world-leading location for biotechnology, is an attractive destination for foreign life science investment and is nurtured by a refreshing focus on innovation in public policy.
Read more about the Australian life science industry or industry highlights.
- Australasian Biotechnology, vol. 27, no.1, AusBiotech, 2017
- Bioshares 2016
- Industry Position Survey 2017
- Scientific American Worldview 2016